Warby Parker (WRBY) Cash & Equivalents (2020 - 2026)
Warby Parker (WRBY) posted Cash & Equivalents of $288.2 million for Q1 2026, up 0.66% on a QoQ basis from $286.4 million in Q4 2025, and up 8.74% year-over-year from $265.1 million in Q1 2025.
Warby Parker (WRBY) Cash & Equivalents (2020 - 2026) Analysis & Trends
Warby Parker's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $288.2 million for Q1 2026.
- Quarterly Cash & Equivalents rose 8.74% year-over-year to $288.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.2 million (up 8.74% YoY) and the FY2025 annual result came in at $286.4 million, up 12.67% from the prior year.
- Cash & Equivalents was $288.2 million for Q1 2026 at Warby Parker, up from $286.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $288.2 million in Q1 2026 and bottomed at $197.9 million in Q3 2022.
- A 5-year average of $239.3 million and a median of $230.3 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents fell 25.67% — and 2025, when it gained 20.35%.
- Warby Parker's Cash & Equivalents stood at $208.6 million in 2022, then grew by 3.98% to $216.9 million in 2023, then increased by 17.18% to $254.2 million in 2024, then increased by 12.67% to $286.4 million in 2025, then rose by 0.66% to $288.2 million in 2026.
- Business Quant data shows WRBY's Cash & Equivalents at $288.2 million in Q1 2026, $286.4 million in Q4 2025, and $280.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Warby Parker | 3.00 Bn | 2.71 Bn | 131.04 Mn | 288.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288.25 Mn |
| Dec 31, 2025 | 286.36 Mn |
| Sep 30, 2025 | 280.36 Mn |
| Jun 30, 2025 | 286.38 Mn |
| Mar 31, 2025 | 265.07 Mn |
| Dec 31, 2024 | 254.16 Mn |
| Sep 30, 2024 | 251.03 Mn |
| Jun 30, 2024 | 237.96 Mn |
| Mar 31, 2024 | 220.38 Mn |
| Dec 31, 2023 | 216.89 Mn |
| Sep 30, 2023 | 215.97 Mn |
| Jun 30, 2023 | 212.66 Mn |
| Mar 31, 2023 | 204.26 Mn |
| Dec 31, 2022 | 208.59 Mn |
| Sep 30, 2022 | 197.89 Mn |
| Jun 30, 2022 | 211.60 Mn |
| Mar 31, 2022 | 230.32 Mn |
| Dec 31, 2021 | 256.42 Mn |
| Sep 30, 2021 | 266.24 Mn |
| Dec 31, 2020 | 314.09 Mn |